Roche Reports a Strong Start to 2025 with 6% Sales Growth in Q1
Roche AG kicks off 2025 with a 6% sales increase in Q1, driven by an 8% growth in pharmaceuticals. CEO Schinecker outlines a $50 billion US expansion plan to innovate healthcare so...
Roche AG kicks off 2025 with a 6% sales increase in Q1, driven by an 8% growth in pharmaceuticals. CEO Schinecker outlines a $50 billion US expansion plan to innovate healthcare so...